z-logo
open-access-imgOpen Access
Extensively Drug-Resistant Typhoid Fever in the United States
Author(s) -
Michael Hughes,
Meseret G. Birhane,
Layne Dorough,
Jared Reynolds,
Hayat Caidi,
Kaitlin A. Tagg,
Caroline M Snyder,
Alexander T. Yu,
Shana M Altman,
Michelle M. Boyle,
Deepam Thomas,
Amy E Robbins,
HaeNa A Waechter,
Irina Cody,
Eric D. Mintz,
Bruce Gutelius,
Gayle Langley,
Louise Francois Watkins
Publication year - 2021
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofab572
Subject(s) - typhoid fever , medicine , azithromycin , enteric fever , empiric therapy , drug , intensive care medicine , pediatrics , virology , antibiotics , alternative medicine , microbiology and biotechnology , pharmacology , pathology , biology
Cases of extensively drug-resistant (XDR) typhoid fever have been reported in the United States among patients who did not travel internationally. Clinicians should consider if and where the patient traveled when selecting empiric treatment for typhoid fever. XDR typhoid fever should be treated with a carbapenem, azithromycin, or both.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom